BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lei S, Chen X, Wu J, Duan X, Men K. Small molecules in the treatment of COVID-19. Signal Transduct Target Ther 2022;7:387. [PMID: 36464706 DOI: 10.1038/s41392-022-01249-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chavda VP, Teli D, Balar PC, Vaghela D, Solanki HK, Vaishnav A, Vora L. Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population. Molecules 2023;28. [PMID: 36903575 DOI: 10.3390/molecules28052332] [Reference Citation Analysis]
2 Wu T, Li J, Hu Y, Tang LV. Hematological Questions in Personalized Management of COVID-19 Vaccination. J Pers Med 2023;13. [PMID: 36836493 DOI: 10.3390/jpm13020259] [Reference Citation Analysis]
3 Dhingra N, Bhardwaj R, Bhardwaj U, Kapoor K. Design of hACE2-based small peptide inhibitors against spike protein of SARS-CoV-2: a computational approach. Struct Chem 2023;:1-14. [PMID: 36714014 DOI: 10.1007/s11224-023-02125-z] [Reference Citation Analysis]
4 Semenov VA, Krivdin LB. The Development of Pharmacophore Models for the Search of New Natural Inhibitors of SARS-CoV-2 Spike RBD-ACE2 Binding Interface. Molecules 2022;27. [PMID: 36558067 DOI: 10.3390/molecules27248938] [Reference Citation Analysis]